The report predicts the Preimplantation genetic testing market is projected to grow at a CAGR of 10.0% during the forecast period from 2022 – 2031.
The global preimplantation genetic testing market is expected to reach USD 541.8 million by 2031 from USD 336.4 million in 2022, at a CAGR of 10.0%. The growing rate of infertility across the globe, increasing public-private investments in the field of preimplantation genetic testing, rising number of fertility clinics worldwide, technological advancements in the field of genetic analysis, and high risk of chromosomal abnormalities in the fetus with increasing maternal age are some of the key factors driving the growth of this market. However, the high procedural cost associated with preimplantation genetic testing and unsupportive government regulations are the factors restraining the growth of this market
“Next-generation Sequencing is expected to grow at the highest CAGR during 2022 to 2031”
By technology, the preimplantation genetic testing market covers next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and single-nucleotide polymorphism (SNP). The NGS segment is expected to grow at the highest CAGR from 2022 to 2031, owing to benefits like reduced cost, better ability to detect an embryo with differing results (mosaicism), enhanced detection of structural abnormalities such as chromosomes with missing or duplicate segments, and reduction in human errors due to increased automation.
“The maternity centers & fertility clinics to dominate the global preimplantation genetic testing market during the forecast period”
On the basis of end users, the preimplantation genetic testing market is segmented into maternity centers & fertility clinics; hospitals, diagnostic labs, and service providers; and research laboratories & academic institutes. The maternity centers & fertility clinics segment accounted for the largest share of the global preimplantation genetic testing market in 2016 owing to the high success rate of treatments at fertility centers.
“APAC is projected to witness the highest growth during the forecast period “
While North America accounted for the largest share of the market in 2016, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2022 to 2031. This is owing to the focus of key market players in this region, a growing number of ART & IVF procedures in the region, continuous decline in average fertility rate, government initiatives for expansion and modernization of healthcare infrastructure across respective countries, and growing medical tourism across APAC countries.
Download The Sample PDF Report Here: https://www.sdki.us/sample-request-108480
Breakdown of supply-side primary interviews: by company type, designation, and region:
- By Company Type – Tier 1 –50%, Tier 2 –33% and Tier 3 –17%
- By Designation – C level – 17%, Director level – 50%, Others – 33%
- By Region – North America – 34%, Europe – 26%, APAC – 35%, RoW – 5%
The major players in the market are Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), CooperSurgical, Inc. (U.S.), Beijing Genomics Institute (BGI) (China), Abbott Laboratories (U.S.), Natera, Inc. (U.S.), Genea Limited (Australia), Rubicon Genomics, Inc. (U.S.), and Oxford Gene Technology (U.K.), among others.
Research Coverage
This report studies the preimplantation genetic testing market based on technology, product & service, procedure type, application, and end user. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.
Reasons to Buy the Report:
This research focuses on various levels of analysis—industry trends, vendor dive analysis of 25 market players, and company profiles of top 15 market players—which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the preimplantation genetic testing market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.
Click Here To Get The Sample PDF Report Here: https://www.sdki.us/sample-request-108480
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on business strategies adopted by the major players in the preimplantation genetic testing market. The report analyzes the preimplantation genetic testing market based on technology, product & service, procedure type, application, end user, and region
- Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product launches in the preimplantation genetic testing market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various preimplantation genetic testing products across geographies
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the preimplantation genetic testing market
- Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the preimplantation genetic testing market
About SDKI :
The dynamic nature of the business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count ( SDKI ) provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.
For more information, please contact:
Lauren Brown
Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790